The metabolism assays market is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8% during the forecast period. The growing research funding and investments, drug development, increase in the metabolic disease prevalence, rise in pharma and biotech investments in research, and increase in personalization of medicines to drive the market.
The metabolism assays market is fragmented. The major players operating in this market are Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), Kaneka Eurogentec S.A. (Belgium), and Sartorius AG (Germany). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities to further expand their presence in the metabolism assays market.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher is the leading player in the metabolism assays market. The company has a strong presence in North America, Europe, Asia Pacific, and Latin America, as well as numerous subsidiaries and distribution channels. Thermo Fisher’s strategic acquisition of PPD in December 2021 demonstrate the company’s commitment to expanding its portfolio and market presence. These acquisitions contribute to Thermo Fisher’s financial success and position the company as a leading player in the life science sector.
Merck KGaA (Germany)
Merck is the second leading player in the metabolism assays market. The company is globally present including Europe, North America, Asia Pacific, Latin America, the Middle East & Africa. Majorly, Merck focuses on external partnerships in its R&D operations, in-house research and maximizing research efficiency while reducing financial outlays. A solid foundation for the continued development of safe and cost-effective products has been provided by the Merck’s strong heritage of technology, leadership, and innovation.
Abcam is a leading player in the global metabolism assays market. The company offers robust products. It has a wide geographic presence in North America, Europe, Asia Pacific, and the Middle East & Africa. Across the globe, Abcam has direct and indirect distribution network, which will protect the company’s business from building fluctuations in demand in various geographies.
Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE